Are you sure you want to log out?
You can always login again from the home screen

Thank You

Thank you for your feedback

COVID-19

COVID-19

8 in 10 people deal with brain fogging after long COVID

COVID-19

Omicron infected exhale 1000 times more viral RNA than other variants

COVID-19

Never seen before symptoms of Omicron on the rise

COVID-19

No signs of slowing down! SARS-CoV-2 evolving each day

COVID-19

New Omicron variants stronger than ever

COVID-19

Four new, highly transmissible Omicron variants picking up

COVID-19

Allergic Rhinitis found to be protective against COVID-19

COVID-19

Risk of heart disease persists months after recovery from COVID-19

COVID-19

COVID rebound fiercer after anti-viral treatment

COVID-19

Smoking and COVID-19 : Decoding the link

COVID-19

Incubation period of SARS-CoV-2 variants helps determine isolation period in COVID-19 : Study

COVID-19

The rise of BA.4 and BA.5 Omicron variants

COVID-19

COVID-19 patients with no symptoms are two-thirds less likely to pass the virus to others

COVID-19

Long COVID still a risk, even for vaccinated people

COVID-19

COVID-19 Pandemic vs. Endemic

COVID-19

Long COVID (post-COVID syndrome): Brain fog

COVID-19

COVID-19 vaccine protection among US children and adolescents amid the Omicron variant surge

COVID-19

WHO issues new COVID-19 guidelines, April, 2022

COVID-19

COVID-19 outbreak seeded by Omicron variants in Hong Kong: Superspreading and transmission heterogeneity

COVID-19

Covid-19 severity in diabetes and non-diabetes

COVID-19

SARS-CoV-2 C.1.2: Emergence, phenotypic characterization, vaccine efficacy

COVID-19

Covid-19 management in children

COVID-19

Why therapeutic monoclonal antibodies have limited or no efficacy against SARS-CoV-2 Omicron BA.2 variant?

COVID-19

Antiviral activity assessment of remdesivir and GS-441524 against Delta, Omicron, and other emergent SARS-CoV-2 variants

COVID-19

Do antibody and antiviral treatments still work against COVID 19 omicron BA.2 variant?

COVID-19

Pregnancy outcomes among women with COVID-19 infection

COVID-19

ESCMID Guidelines for treatment of long covid

COVID-19

Long Covid: Persistent Symptoms 12 months after discharge

COVID-19

Characterizing long COVID and its impact

COVID-19

Long COVID attributes and predictors

COVID-19

Management of Non-hospitalized COVID-19 patients

COVID-19

Prevalence of fungal infections in mechanically ventilated patients in COVID-19

COVID-19

SARS-CoV2 variants: Transmissibility, resistance to host immunity and molecular diagnosis

COVID-19

Antiviral therapies and SARS-CoV2-host cell surface interactions

COVID-19

Importance of antivirals in curtailing the pandemic

COVID-19

Health implications of the genetic drift in the genome of SARS COV-2

COVID-19

Is SARS-CoV2 Omicron variant more transmissible?

COVID-19

COVID19 Antivirals : Remdesivir to be active against Omicron variant

COVID-19

Keeping pace with ever-evolving COVID-19 pneumonia

COVID-19

Fresh concerns and unanswered questions about new Omicron variant

COVID-19

Antiviral drugs for the future

COVID-19

Delta variant B.1.617.2 is resistant to antibody neuralization

COVID-19

COVID-19 - A seasonal low - temperature infection?

COVID-19

Challenges in diagnosis and treatment of autonomic complications of COVID-19

COVID-19

Covid-19 protection by pre-existing HCoV antibodies

COVID-19

Fully vaccinated individuals may shed infectious COVID-19 virus

COVID-19

Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app

COVID-19

Administration of COVID-19 vaccines in immunocompromised patients

COVID-19

Statins linked to lower mortality in Covid-19

COVID-19

Pulmonary Immunothrombosis leading to hypoxia in COVID-19

COVID-19

Aggravating factors of post covid secondary fungal infections

COVID-19

Burden of new SARS-CoV-2 variants in India

Back to top
Gilead Middle East DataBase “GMED”

Are you sure you want to log out?
You can always login again from the home screen

Thank You

Thank you for your feedback

COVID-19

COVID-19

8 in 10 people deal with brain fogging after long COVID

COVID-19

Omicron infected exhale 1000 times more viral RNA than other variants

COVID-19

Never seen before symptoms of Omicron on the rise

COVID-19

No signs of slowing down! SARS-CoV-2 evolving each day

COVID-19

New Omicron variants stronger than ever

COVID-19

Four new, highly transmissible Omicron variants picking up

COVID-19

Allergic Rhinitis found to be protective against COVID-19

COVID-19

Risk of heart disease persists months after recovery from COVID-19

COVID-19

COVID rebound fiercer after anti-viral treatment

COVID-19

Smoking and COVID-19 : Decoding the link

COVID-19

Incubation period of SARS-CoV-2 variants helps determine isolation period in COVID-19 : Study

COVID-19

The rise of BA.4 and BA.5 Omicron variants

COVID-19

COVID-19 patients with no symptoms are two-thirds less likely to pass the virus to others

COVID-19

Long COVID still a risk, even for vaccinated people

COVID-19

COVID-19 Pandemic vs. Endemic

COVID-19

Long COVID (post-COVID syndrome): Brain fog

COVID-19

COVID-19 vaccine protection among US children and adolescents amid the Omicron variant surge

COVID-19

WHO issues new COVID-19 guidelines, April, 2022

COVID-19

COVID-19 outbreak seeded by Omicron variants in Hong Kong: Superspreading and transmission heterogeneity

COVID-19

Covid-19 severity in diabetes and non-diabetes

COVID-19

SARS-CoV-2 C.1.2: Emergence, phenotypic characterization, vaccine efficacy

COVID-19

Covid-19 management in children

COVID-19

Why therapeutic monoclonal antibodies have limited or no efficacy against SARS-CoV-2 Omicron BA.2 variant?

COVID-19

Antiviral activity assessment of remdesivir and GS-441524 against Delta, Omicron, and other emergent SARS-CoV-2 variants

COVID-19

Do antibody and antiviral treatments still work against COVID 19 omicron BA.2 variant?

COVID-19

Pregnancy outcomes among women with COVID-19 infection

COVID-19

ESCMID Guidelines for treatment of long covid

COVID-19

Long Covid: Persistent Symptoms 12 months after discharge

COVID-19

Characterizing long COVID and its impact

COVID-19

Long COVID attributes and predictors

COVID-19

Management of Non-hospitalized COVID-19 patients

COVID-19

Prevalence of fungal infections in mechanically ventilated patients in COVID-19

COVID-19

SARS-CoV2 variants: Transmissibility, resistance to host immunity and molecular diagnosis

COVID-19

Antiviral therapies and SARS-CoV2-host cell surface interactions

COVID-19

Importance of antivirals in curtailing the pandemic

COVID-19

Health implications of the genetic drift in the genome of SARS COV-2

COVID-19

Is SARS-CoV2 Omicron variant more transmissible?

COVID-19

COVID19 Antivirals : Remdesivir to be active against Omicron variant

COVID-19

Keeping pace with ever-evolving COVID-19 pneumonia

COVID-19

Fresh concerns and unanswered questions about new Omicron variant

COVID-19

Antiviral drugs for the future

COVID-19

Delta variant B.1.617.2 is resistant to antibody neuralization

COVID-19

COVID-19 - A seasonal low - temperature infection?

COVID-19

Challenges in diagnosis and treatment of autonomic complications of COVID-19

COVID-19

Covid-19 protection by pre-existing HCoV antibodies

COVID-19

Fully vaccinated individuals may shed infectious COVID-19 virus

COVID-19

Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app

COVID-19

Administration of COVID-19 vaccines in immunocompromised patients

COVID-19

Statins linked to lower mortality in Covid-19

COVID-19

Pulmonary Immunothrombosis leading to hypoxia in COVID-19

COVID-19

Aggravating factors of post covid secondary fungal infections

COVID-19

Burden of new SARS-CoV-2 variants in India

Back to top